Nrf2 activation suppresses ROS in antigen-presenting dendritic cells enhancing their capacity to interact with and promote the transformation of nave CD8 T cells into cytotoxic T lymphocytes enabling cytotoxic T-cells to eliminate virally infected cells (Kesarwani et al., 2013
The combination is safe, well-tolerated, and synergistic
Patients should be encouraged to prioritize nutrient-dense foods and ensure adequate protein intake (typically 1.2-1.6 g/kg of ideal body weight daily during active weight loss, with higher amounts for those engaging in resistance training)
Targeting these receptors has led to therapies like GLP-1 receptor agonists, improving glycemic control and inducing weight loss, and dual agonists, offering a comprehensive approach to metabolic disorder management
These medications can lead to meaningful weight loss, improve cardiometabolic risk factors, and reduce appetite and food-related preoccupation for many patients